Company / Current Liabilities per Share
Supernus Pharmaceuticals, Inc. Current Liabilities per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$6.07
FY2025
5-year range
$5.23 / $12.92
FY2021-FY2025
Trend
+13.5%
vs FY2024
Sector context
#34 of 210
Health Care
What the data says
Supernus Pharmaceuticals, Inc.'s current liabilities per share of $6.07 is higher than 84% of companies in the Health Care sector (FY2025). Current Liabilities per Share has fluctuated over the past 10 years, ranging from $1.65 in FY2016 to $12.92 in FY2022.
Based on SEC 10-K filings.
6.07 in FY2025 with a 5-year CAGR of +5.4%. Top quartile in the Health Care sector.
Increased from $5.23 to $6.07 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -22.3%
- 5-Year CAGR
- +5.4%
- 10-Year CAGR
- -
Sector benchmark
-74.5% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share increased 13.5% year-over-year.
- Ranks #34 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2022.
- Lowest current liabilities per share in the period was in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.07 | +13.5% |
| FY2024 | $5.34 | +2.2% |
| FY2023 | $5.23 | -59.5% |
| FY2022 | $12.92 | +116.5% |
| FY2021 | $5.97 | +27.9% |
| FY2020 | $4.67 | +52.0% |
| FY2019 | $3.07 | -2.4% |
| FY2018 | $3.14 | +27.7% |
| FY2017 | $2.46 | +49.4% |
| FY2016 | $1.65 | +24.4% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026